Health : Diseases, Disorders, and Disciplines
The Leukemia & Lymphoma Society
Fighting blood cancers
Board Leadership
Peter Brock
Chair
CEO
Louis J. DeGennaro
President and CEO
|
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
Impact Information
What is your organization aiming to accomplish?
What are your strategies for making this happen?
What are your organization's capabilities for doing this?
How will your organization know if you are making progress?
What have and haven't you accomplished so far?
Financial
82.37
Accountability & Transparency
97.00

Program Expenses (Percent of the charity's total expenses spent on the programs and services it delivers) |
75.8% | |
Administrative Expenses | 8.8% | |
Fundraising Expenses | 15.3% | |
Fundraising Efficiency | $0.13 | |
Working Capital Ratio (years) | 0.75 | |
Program Expenses Growth | 10.6% | |
Liabilities to Assets | 38.2% |
REVENUE | |
Contributions | |
Contributions, Gifts & Grants | $244,160,983 |
Federated Campaigns | $1,238,625 |
Membership Dues | $0 |
Fundraising Events | $174,170,889 |
Related Organizations | $0 |
Government Grants | $0 |
Total Contributions | $419,570,497 |
Program Service Revenue | $9,230,125 |
Total Primary Revenue | $428,800,622 |
Other Revenue | $10,054,139 |
TOTAL REVENUE | $438,854,761 |
EXPENSES (Adjusted) | |
Program Expenses | $274,505,959 |
Administrative Expenses | $28,888,484 |
Fundraising Expenses | $53,055,909 |
TOTAL FUNCTIONAL EXPENSES | $356,450,352 |
Payments to Affiliates | $0 |
Excess (or Deficit) for the year | $82,404,409 |
Net Assets | $236,232,374 |
Charts
Compensation | % of Expenses | Paid to | Title | |
---|---|---|---|---|
$634,681 | 0.17% | Louis J. DeGennaro | President, CEO |
Mission
The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, multiple myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world, provides free information and support services, and is the voice for all blood cancer patients seeking access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org. Patients should contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET.
Highly Rated
Charity Name & State | Overall Score | Overall Rating |
---|---|---|
The Leukemia & Lymphoma Society (NY) | 87.35 | |
Florida Breast Cancer Foundation (FL) | 100.00 | |
The V Foundation (NC) | 95.79 | |
Colon Cancer Coalition (MN) | 86.69 | |
International Waldenstrom's Macroglobulinemia Foundation (FL) | 95.29 |